iotaMotion Achieves FDA Clearance for Pediatric Use
iotaMotion, Inc., a pioneering medical technology company, has recently received FDA 510(k) clearance for its innovative iotaSOFT® robotic-assisted cochlear implant insertion system. This milestone enables the use of the system in children aged four years and older, expanding access to vital cochlear implantation procedures for school-aged children. With this advancement, iotaMotion reinforces its commitment to transforming medial procedures and enhancing patient outcomes.
Importance of the iotaSOFT® System
The iotaSOFT® system represents a significant technological achievement, notable for being the first FDA-cleared robotic-assisted cochlear implant system. By standardizing electrode array insertion during cochlear implant surgeries, it aims to eliminate variability during one of the most delicate steps of the procedure, allowing for precise and controlled insertion. This precision is crucial in preserving delicate cochlear structures, which is often a major concern for parents considering cochlear implants for their children.
First Pediatric Center Adopts iotaSOFT® System
In a groundbreaking move, Cincinnati Children's Hospital has become the first pediatric medical center to adopt the iotaSOFT® Insertion System. This prestigious institution, known for its commitment to providing top-tier medical care, joins over 35 leading cochlear implant centers across the country in utilizing this innovative technology. Dr. Daniel Choo, chief clinical growth officer at Cincinnati Children's, highlighted its role in enhancing their cochlear implant program by integrating cutting-edge innovations for improved patient care.
Addressing Global Cochlear Implant Needs
Despite the advancements in cochlear implant technology, fewer than 5% of eligible candidates globally receive implants. Many face challenges related to surgical variability and concerns about hearing preservation. With over 430 million individuals experiencing disabling hearing loss worldwide, early access to sound is critical for the development of language and educational skills in pediatric patients. The iotaSOFT® system's introduction can potentially alter these statistics by providing a reliable means of implantation.
Clinical Evidence Supporting Robotic Assistance
Recent studies showcase the effectiveness of robotic assistance in cochlear implantation. A key study featured in The Laryngoscope noted that 85% of patients who underwent robotic-assisted insertion maintained hearing preservation after one year, contrasting with 71% from the manual insertion group. This data highlights the considerable advantages of robotic-assisted technology in enhancing surgical outcomes and patient confidence.
Marlan Hansen, MD, a co-founder and chief medical officer of iotaMotion, expressed optimism regarding the expanded pediatric indication for the iotaSOFT system. He emphasized that standardized and controlled insertion techniques are essential in preserving the cochlea's structures and function. This is particularly significant for children, as it aligns with potential future therapeutic approaches in hearing restoration.
About iotaMotion
iotaMotion, Inc. is at the forefront of advancing cochlear implant surgery using robotic-assisted technologies. With its flagship product, the iotaSOFT® Insertion System, iotaMotion aims to provide a solution that enhances the quality of life for hearing-impaired patients. Its commitment to addressing intricacies involved in cochlear surgery reflects a dedication to improving surgical methodologies while ensuring patient safety and viability.
For more information about the company and its innovative technologies, please visit the official iotaMotion website and connect with them on their social media platforms.
Frequently Asked Questions
What is the iotaSOFT® System?
The iotaSOFT® System is a robotic-assisted cochlear implant insertion system designed to provide precise and controlled electrode array insertion to optimize cochlear implant surgeries.
Who can use the iotaSOFT® System?
With FDA clearance, the iotaSOFT® System can now be used for patients aged four years and older, allowing for expanded access for pediatric patients.
What benefits does robotic assistance offer in cochlear implantation?
Robotic assistance enhances precision and reduces variability during surgery, which aids in preserving delicate cochlear structures and improving surgical outcomes.
Why is early cochlear implantation important for children?
Early cochlear implantation is crucial for aiding speech, language, and educational development in children, helping to facilitate their growth and learning processes.
Where can I find more information about iotaMotion?
More information on iotaMotion and their technologies can be found on their official website and various social media platforms where they share updates and developments.
